Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: The partnership for rapid elimination of trachoma (PRET) in Tanzania and the Gambia

Ophthalmic Epidemiology

Volumn 18, Issue 1, 2011, Pages 20-29

  Stare, Dianne ^a   Harding Esch, Emma ^b   Munoz, Beatriz ^a   Bailey, Robin ^b   Mabey, David ^b   Holland, Martin ^b,c   Gaydos, Charlotte ^d   West, Sheila ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

C. trachomatis; Community based trial; Tanzania; The Gambia; Trachoma

Indexed keywords

AZITHROMYCIN; TETRACYCLINE;

ARTICLE; BACTERIAL EYE INFECTION; CHILD; CHLAMYDIA TRACHOMATIS; COMMUNITY; DRUG EFFICACY; FACTORIAL DESIGN; FEMALE; GAMBIA; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TANZANIA; TRACHOMA;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD, PRESCHOOL; CHLAMYDIA INFECTIONS; FEMALE; GAMBIA; HUMANS; MALE; PREVALENCE; QUALITY ASSURANCE, HEALTH CARE; RESEARCH DESIGN; SINGLE-BLIND METHOD; TANZANIA; TRACHOMA;

EID: 79551571785     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.3109/09286586.2010.545500     Document Type: Article

References (24)

1. Mariotti, SP, Pascolini, D, Rose-Nussbaumer, J. Trachoma: Global magnitude of a preventable cause of blindness. Br J Ophthalmol 2009; 93(5):563-568.
2. Jansen, E, Baltussen, RM, van Doorslaer E, Ngirwamungu E, Nguyen MP, Kilima PM. An eye for inequality: how trachoma relates to poverty in Tanzania and Vietnam. Ophthalmic Epidemiol 2007; 14(5):278-287.
3. Frick, KD, Basilion, EV, Hanson, CL, Colchero, MA. Estimating the burden and economic impact of trachomatous visual loss. Ophthalmic Epidemiol 2003; 10(2):121-132.
4. Baltussen, RM, Sylla, M, Frick, KD, Mariotti, SP. Costeffectiveness of trachoma control in seven world regions. Ophthalmic Epidemiol 2005; 12(2):91-101
5. Solomon, AW, Zondervan, M, Kuper, H, Buchan, JC, Mabey, DCW, Foster, A. Trachoma control: a guide for programme managers. Geneva, Switzerland: World Health Organization; 2006.
6. Report of the Eighth Meeting of the WHO Alliance for the Global Elimination of blinding Trachoma. Report of a WHO Working Group. 2004; World Health Organization Geneva, Switzerland. WHO/PBD/GET/04.2
7. Burton, MJ, Holland, MJ, Makalo, P, Aryee, EA, Alexander, ND, Sillah, A, et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 2005; 365(9467):1321-1328.
8. Solomon, AW, Holland, MJ, Alexander, ND, Massae, PA, Aguirre, A, Natividad-Sancho, A, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 2004; 351(19):1962-1971.
9. Melese, M, Chidambaram, JD, Alemayehu, W, Lee, DC, Yi, EH, Cevallos, V, et al. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA 2004; 292(6):721-725.
10. Chidambaram, JD, Alemayehu, W, Melese, M, Lakew, T, Yi, E, House, J, et al. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA 2006; 295(10):1142-1146.
11. West, SK, Munoz, B, Mkocha, H, Holland, MJ, Aguirre, A, Solomon, AW, et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 2005; 366(9493):1296-1300.
12. Solomon, AW, Harding-Esch, E, Alexander, ND, Aguirre, A, Holland, MJ, Bailey, RL, et al. Two doses of azithromycin to eliminate trachoma in a Tanzanian community. N Engl J Med 2008; 358(17):1870-1871.
13. Bailey, RL. rRNA-based tests for chlamydial infection in trachoma. Br J Ophthalmol 2007; 91(3):271.
14. Mkocha, H, Munoz, B, West, S. Trachoma and ocular Chlamydia trachomatis rates in children in trachoma-endemic communities enrolled for at least three years in the Tanzania National Trachoma Control Programme. Tanzania Journal of Health Research 2009; 11(3):103-10.
15. Faal, H, Minassian, DC, Dolin, PJ, Mohamed, AA, Ajewole, J, Johnson, GJ. Evaluation of a national eye care programme: re-survey after 10 years. Br J Ophthalmol 2000 Sept; 84(9):948-951.
16. Dolin, PJ, Faal, H, Johnson, GJ, Ajewole, J, Mohamed, AA, Lee, PS. Trachoma in the Gambia. Br J Ophthalmol 1998 Aug; 82(8):930-933.
17. Harding-Esch, E, Edwards, T, Sillah, A, Sarr, I, Roberts, CH, Snell, P, et al. Active trachoma and ocular Chlamydia trachomatis infection and in two Gambian regions: on course for 2020? PLoS Negl Trop Dis 2009 Dec 22; 3(12):e573.
18. Chow, SC, Shao, J, Wang, H. Sample size calculations in clinical research. Boca Raton: Taylor and Francis; 2003.
19. Chaudhary, MA, Moulton, LH. A SAS macro for constrained randomization of group-randomized designs. Comput Methods Programs BioMed 2006; 83(3):205-210.
20. Thylefors, B, Dawson, CR, Jones, BR, West, SK, Taylor, HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987; 65(4):477-483.
21. Solomon, AW, Holland, MJ, Burton, MJ, West, SK, Alexander, ND, Aguirre, A, et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet 2003; 362(9379):181-182.
22. Dalesio, NV, Marsiglia, A, Quinn, TC, Quinn, CA, Gaydos, CA. Performance of the MagnaNA Pure LC for the extraction of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and swab specimens. J. Clin Microbiol 2004; (42):3300-3302.
23. Diamant, J, Benis, R, Schachter, J, Moncada, J, Pang, F, Jha, HC, et al. Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection. Opthalmic Epidemiol 2001; 8(2-3):109-117.
24. Mathew, AA, Turner, A, Taylor, HR. Strategies to control trachoma. Drugs 2009; 69(8):953-970.